Linked Life Data

18544744

Source:http://linkedlifedata.com/resource/pubmed/id/18544744

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2008-6-18
pubmed:abstractText
In the Raloxifene Use for The Heart trial, 10 101 postmenopausal women with coronary heart disease (CHD) or multiple CHD risk factors were randomly assigned to 60 mg/d raloxifene or to placebo and followed for a median of 5.6 years. Raloxifene, a selective estrogen receptor modulator, was found to reduce the risk of invasive breast cancer and vertebral fractures but not the risk of cardiovascular events. Here, we provide further details about breast cancer incidence by tumor characteristics, duration of treatment, and subgroup.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1460-2105
pubmed:author
pubmed:issnType
Electronic
pubmed:day
18
pubmed:volume
100
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
854-61
pubmed:meshHeading
pubmed-meshheading:18544744-Aged, pubmed-meshheading:18544744-Antineoplastic Agents, Hormonal, pubmed-meshheading:18544744-Bone Density Conservation Agents, pubmed-meshheading:18544744-Breast Neoplasms, pubmed-meshheading:18544744-Coronary Disease, pubmed-meshheading:18544744-Female, pubmed-meshheading:18544744-Fractures, Bone, pubmed-meshheading:18544744-Humans, pubmed-meshheading:18544744-Incidence, pubmed-meshheading:18544744-Lymphatic Metastasis, pubmed-meshheading:18544744-Middle Aged, pubmed-meshheading:18544744-Neoplasm Invasiveness, pubmed-meshheading:18544744-Neoplasm Staging, pubmed-meshheading:18544744-Odds Ratio, pubmed-meshheading:18544744-Osteoporosis, Postmenopausal, pubmed-meshheading:18544744-Proportional Hazards Models, pubmed-meshheading:18544744-Raloxifene, pubmed-meshheading:18544744-Risk Assessment, pubmed-meshheading:18544744-Risk Factors, pubmed-meshheading:18544744-Selective Estrogen Receptor Modulators, pubmed-meshheading:18544744-Spine
pubmed:year
2008
pubmed:articleTitle
Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk.
pubmed:affiliation
University of California, San Francisco, and San Francisco VA Medical Center, San Francisco, CA 94115, USA. deborah.grady@ucsf.edu
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't